According to the National Institutes of Health (NIH), Alzheimer's disease (AD) -- which robs people of the ability to think, remember and reason -- is an irreversible, progressive disease that eventually destroys even the ability to carry ...
The Brain & Behavior Research Foundation (BBRF) (formerly known as NARSAD, the National Alliance for Research on Schizophrenia and Depression), under the direction of president and CEO Dr Jeffrey Borenstein, has announced the latest ...
Tags: Narsad, BBRF, investigator, award
NANOTECHNOLOGY is a hot topic in science. Not a day goes by without news of some clever device forged using components measuring billionths of a metre. But as is often the case, Mother Nature got there long before humans did. Living cells ...
Biopharmaceutical company Trigemina will deliver clinical data on its drug candidate TI-001 for the treatment of chronic migraine at the ongoing 7th Annual Pain Therapeutics Summit East in Boston, Massachusetts. The presentation will ...
Tags: Migraine Drug, Medicine
A multiple-sclerosis drug that was at the center of Sanofi SA's SAN.FR +1.12% $20 billion takeover battle for Genzyme Corp. three years ago was approved for sale in Europe on Tuesday, the drug's first regulatory approval world-wide. The ...
Health Canada has accepted to review Sunovion Pharmaceuticals Canada's (Sunovion) new drug submission (NDS) for eslicarbazepine acetate for use as a once-daily adjunctive therapy for the treatment of partial-onset seizures in patients aged ...
US regulatory authorities have allowed the marketing of a brain wave test, which can diagnose attention-deficit/hyperactivity disorder (ADHD) in children and adolescents aged between six and 17 years. This device, called Neuropsychiatric ...
The results were based on a study on more than 30,000 people. It found that the general population’s exposure to the chemical was too low to have any toxic effects. Experts have claimed that range of human disorders including ...
A new study conducted by researchers at Duke University Medical Centre in Durham, North Carolina has revealed that environmental exposure to bisphenol A (BPA) may suppress a gene important to nerve cell function and to the development of ...
Tags: Packaging, plastic water bottles, metal cans
Phytopharm has announced results of its Phase II, randomised trial of Cogane in unmedicated patients with Parkinson's disease. More than four hundred subjects with early-stage Parkinson's disease were randomly chosen to receive either ...
Tags: PhytopharmPhase II, randomised trial, Parkinson's disease